Literature DB >> 15365284

Diuretic-related side effects: development and treatment.

Doemnic A Sica1.   

Abstract

Diuretics are important therapeutic tools. First, they effectively reduce blood pressure and have been shown in numerous hypertension clinical trials to reduce both cardiovascular and cerebrovascular morbidity and mortality. In addition, their use has been equally effective in controlling cardiovascular events as angiotensin-converting enzyme inhibitors or calcium channel blockers. Diuretics are currently recommended by the Seventh Report of the Joint National Commission on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure report as first-line therapy for the treatment of hypertension. In addition, they remain an important aspect of congestive heart failure treatment in that they improve the congestive symptomatology, which typifies the more advanced stages of congestive heart failure. This article reviews the commonly encountered side effects with the various diuretic classes. Where indicated, the mechanistic basis and treatment of such side effects is further discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15365284      PMCID: PMC8109680          DOI: 10.1111/j.1524-6175.2004.03789.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  82 in total

1.  Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)

Authors:  R H Grimm; G A Grandits; R J Prineas; R H McDonald; C E Lewis; J M Flack; C Yunis; K Svendsen; P R Liebson; P J Elmer
Journal:  Hypertension       Date:  1997-01       Impact factor: 10.190

2.  Effect of furosemide on antibiotic-induced renal damage in rats.

Authors:  D H Lawson; R F Macadam; M H Singh; H Gavras; S Hartz; D Turnbull; A L Linton
Journal:  J Infect Dis       Date:  1972-12       Impact factor: 5.226

Review 3.  Control by drugs of renal potassium handling.

Authors:  H Velázquez; F S Wright
Journal:  Annu Rev Pharmacol Toxicol       Date:  1986       Impact factor: 13.820

4.  Phototoxic potential of thiazide diuretics in normal subjects.

Authors:  B L Diffey; J Langtry
Journal:  Arch Dermatol       Date:  1989-10

Review 5.  Treatment of symptomatic hyponatremia.

Authors:  Guy Decaux; Alain Soupart
Journal:  Am J Med Sci       Date:  2003-07       Impact factor: 2.378

Review 6.  Hyperkalemia, congestive heart failure, and aldosterone receptor antagonism.

Authors:  Domenic A Sica; Todd W B Gehr; Clyde Yancy
Journal:  Congest Heart Fail       Date:  2003 Jul-Aug

Review 7.  Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients.

Authors:  M Sonnenblick; Y Friedlander; A J Rosin
Journal:  Chest       Date:  1993-02       Impact factor: 9.410

8.  Comparative effect of diuretics on renal water excretion in hyponatraemic oedematous disorders.

Authors:  V L Szatalowicz; P D Miller; J W Lacher; J A Gordon; R W Schrier
Journal:  Clin Sci (Lond)       Date:  1982-02       Impact factor: 6.124

9.  Efficacy and tolerance of spironolactone in essential hypertension.

Authors:  X Jeunemaitre; G Chatellier; C Kreft-Jais; A Charru; C DeVries; P F Plouin; P Corvol; J Menard
Journal:  Am J Cardiol       Date:  1987-10-01       Impact factor: 2.778

Review 10.  Sexual dysfunction in hypertensive men. A critical review of the literature.

Authors:  S Bansal
Journal:  Hypertension       Date:  1988-07       Impact factor: 10.190

View more
  33 in total

Review 1.  Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics.

Authors:  Julio D Duarte; Rhonda M Cooper-DeHoff
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-06

Review 2.  Metabolic safety of antihypertensive drugs: myth versus reality.

Authors:  Sameer Stas; Lama Appesh; James Sowers
Journal:  Curr Hypertens Rep       Date:  2006-10       Impact factor: 5.369

3.  Loop diuretics decrease the renal elimination rate and increase the plasma levels of trimethylamine-N-oxide.

Authors:  G Latkovskis; E Makarova; M Mazule; L Bondare; D Hartmane; H Cirule; S Grinberga; A Erglis; E Liepinsh; M Dambrova
Journal:  Br J Clin Pharmacol       Date:  2018-09-06       Impact factor: 4.335

4.  Hydrochlorothiazide-induced hyperuricaemia in the pharmacogenomic evaluation of antihypertensive responses study.

Authors:  A G Vandell; C W McDonough; Y Gong; T Y Langaee; A M Lucas; A B Chapman; J G Gums; A L Beitelshees; K R Bailey; R J Johnson; E Boerwinkle; S T Turner; R M Cooper-DeHoff; J A Johnson
Journal:  J Intern Med       Date:  2014-02-28       Impact factor: 8.989

Review 5.  Diuretic use in renal disease.

Authors:  Domenic A Sica
Journal:  Nat Rev Nephrol       Date:  2011-12-20       Impact factor: 28.314

Review 6.  Metabolic effects of antihypertensive agents: role of sympathoadrenal and renin-angiotensin systems.

Authors:  Paul Ernsberger; Richard J Koletsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-06-17       Impact factor: 3.000

7.  An evaluation of a potential calcium channel blocker-lower-extremity edema-loop diuretic prescribing cascade.

Authors:  Scott Martin Vouri; Joseph S van Tuyl; Margaret A Olsen; Hong Xian; Mario Schootman
Journal:  J Am Pharm Assoc (2003)       Date:  2018-07-20

8.  Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes.

Authors:  Allan J Collins; Bertram Pitt; Nancy Reaven; Susan Funk; Karen McGaughey; Daniel Wilson; David A Bushinsky
Journal:  Am J Nephrol       Date:  2017-09-02       Impact factor: 3.754

Review 9.  Type 2 Diabetes and Thiazide Diuretics.

Authors:  André J Scheen
Journal:  Curr Diab Rep       Date:  2018-02-05       Impact factor: 4.810

10.  Evaluation of a Common Prescribing Cascade of Calcium Channel Blockers and Diuretics in Older Adults With Hypertension.

Authors:  Rachel D Savage; Jessica D Visentin; Susan E Bronskill; Xuesong Wang; Andrea Gruneir; Vasily Giannakeas; Jun Guan; Kenneth Lam; Miles J Luke; Stephanie H Read; Nathan M Stall; Wei Wu; Lynn Zhu; Paula A Rochon; Lisa M McCarthy
Journal:  JAMA Intern Med       Date:  2020-05-01       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.